WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.97%)Nav, as on 20-05-2025

  • Previous Nav

  • Net Change on 20-05-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 14.06 21.99 22.14 1.80 8,259.60
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 22.79 26.82 25.44 1.91 5,295.32
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 19.94 25.88 24.46 1.94 3,670.62
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 13.20 22.31 23.72 1.94 2,912.01
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 17.37 20.45 22.21 1.94 2,682.70

Fund Holdings as on 30-April-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Divi's Laboratories Limited

  • Max Healthcare Institute Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Laurus Labs Limited

  • Krishna Institute Of Medical Sciences Limited

  • Fortis Healthcare Limited

  • IPCA Laboratories Limited

  • Clearing Corporation of India Ltd

  • Apollo Hospitals Enterprise Limited

  • Abbott India Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Ajanta Pharma Limited

  • Neuland Laboratories Limited

  • Piramal Pharma Limited

  • Poly Medicure Limited

  • Kovai Medical Center and Hospital Limited

  • Mankind Pharma Limited

  • Thyrocare Technologies Limited

  • Aurobindo Pharma Limited

  • Jupiter Life Line Hospitals Limited

  • Global Health Limited

  • Rainbow Childrens Medicare Limited

  • 91 Days Tbill (MD 11/07/2025)

  • Alembic Pharmaceuticals Limited

  • Eris Lifesciences Limited

  • Ami Organics Limited

  • Vijaya Diagnostic Centre Limited

  • 91 Days Tbill (MD 08/05/2025)

  • Strides Pharma Science Limited

  • FDC Limited

  • Dr. Reddy's Laboratories Limited

  • Supriya Lifescience Limited

  • RPG Life Sciences Limited

  • Net Receivables / (Payables)

  • Laxmi Dental Limited

  • Navin Fluorine International Limited

  • Emcure Pharmaceuticals Limited

  • 364 Days Tbill (MD 23/05/2025)

  • Shaily Engineering Plastics Limited

  • Jubilant Ingrevia Limited

  • Dr.Agarwals Eye Hospital Limited

  • Alkyl Amines Chemicals Limited

  • PB Fintech Limited

  • 91 Days Tbill (MD 19/06/2025)

  • 91 Days Tbill (MD 26/06/2025)

  • 182 Days Tbill (MD 05/06/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Plastic Products

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹320.45 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.13(-0.97%)yesterday to ₹12.786.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643